CD8A and autoimmune thrombocytopenic purpura: Patients with more CD8+ T cells or a lower CD4+ T/CD8+ T cell ratio before treatment are less sensitive to the first-line therapy, making the level of CD8+ T cells a useful prognostic indicator for patients with ITP, especially the elderly (99).